• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>ViroPharma

ViroPharma

  1. Shire Receives US$248 Million Cash Refund From the Canadian Revenue Authorities, Expects a Further US$162 Million in Late 2014

    Shire Receives US$248 Million Cash Refund From the Canadian Revenue Authorities, Expects a Further US$162 Million in Late 2014

  2. Shire Confirms Rejection of AbbVie Proposal

    Shire Confirms Rejection of AbbVie Proposal

  3. Shire rebuffs $46 billion takeover bid from AbbVie

    Shire rebuffs $46 billion takeover bid from AbbVie

1
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.